Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Early diagnosis and prednisone treatment can improve outcomes in Cronkhite-Canada syndrome.

Hair cortisol measurement can help diagnose and monitor Cushing’s disease.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Glucocorticoid and mineralocorticoid therapy effectively manage Congenital Adrenal Hyperplasia symptoms but have limitations.

Inhaled substances in e-cigarettes can cause hormone imbalances similar to congenital adrenal hyperplasia.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Untreated Sheehan's Syndrome caused severe heart failure in a woman, which improved with hormone and heart failure treatment.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Steroids, infection management, and nutritional support can significantly improve symptoms of Cronkhite-Canada Syndrome.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

A young girl's hyperandrogenism was caused by an adrenocortical adenoma, diagnosed and treated through detailed evaluations.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

Consider rare forms of CAH for accurate diagnosis and treatment.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Cats can have hypersomatotropism without diabetes, suggesting current diagnosis methods may miss cases.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Cyclosporine can cause a unique skin condition called "cyclosporine-induced folliculodystrophy."

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The patient's hypothyroidism improved with medication adjustments and careful management.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

A CCS patient with severe complications was successfully treated using combined therapies.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

A dog developed skin issues from too many steroids, but reducing steroids and using a specific treatment fixed the problems.

A diabetic cat with another gland issue got better after treatment with cabergoline, no longer needing insulin.